...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis.
【24h】

Percutaneous portal vein thrombolysis and endovascular stent for management of posttransplant portal venous conduit thrombosis.

机译:经皮门静脉溶栓和血管内支架用于治疗移植后门静脉导管血栓形成。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Thrombosis of a portal vein conduit after liver transplant is an uncommon clinical situation. Percutaneous thrombolytic therapy for this condition has not been widely described. METHODS: We describe a case of thrombosis of a portal vein (PV) conduit subsequent to orthotopic liver transplantation that was successfully treated by percutaneous portal vein thrombolysis by using tissue plasminogen activator, angioplasty, and endovascular stent placement. RESULTS: A satisfactory outcome was achieved with a patent portal vein, on ultrasound, at 8-month follow-up. CONCLUSION: A percutaneous transhepatic approach to treatment of thrombosis of a portal vein conduit appears to be a promising technique to use to avoid surgery, with good medium-term results.
机译:背景:肝移植后门静脉导管的血栓形成是一种罕见的临床情况。对于这种情况的经皮溶栓治疗尚未得到广泛描述。方法:我们描述了原位肝移植后门静脉(PV)导管血栓形成的情况,该病例通过使用组织纤溶酶原激活物,血管成形术和血管内支架置入术经皮门静脉溶栓术成功治疗。结果:在8个月的随访中,经超声检查获得了专利的门静脉获得了满意的结果。结论:经皮肝穿刺治疗门静脉导管血栓形成似乎是避免手术的有前途的技术,中期效果良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号